Insights

Cutting-edge Drug Development Vesselon Inc. is at the forefront of pharmaceutical manufacturing, focusing on developing patentable drugs that utilize advanced biophysically activatable lipid microsphere and self-assembling liposome platform. This cutting-edge approach offers unprecedented efficacy, creating a unique selling point for potential sales.

Exclusive Licensing Agreement The recent exclusive licensing agreement with Temple University for patent enabling oncolytic viruses delivery for solid tumors presents a significant sales opportunity. This partnership opens doors for innovative solutions and expansion in the oncology market segment.

Innovative Therapeutic Complex Vesselon Inc.'s development of VEST™, a novel therapeutic immuno-oncology complex designed to protect and target tumors, offers a compelling product for potential sales. This innovative product can address unmet needs in the market and attract interest from healthcare institutions and professionals.

Product Acquisition Impact The acquisition of FDA-approved drug Imagent by Vesselon Inc. demonstrates the company's strategic growth and diversification in the pharmaceutical sector. This new addition to their product portfolio provides a strong sales opportunity, showcasing the company's commitment to expanding its offerings.

Focused Market Positioning With a focus on oncology therapeutics and groundbreaking drug development, Vesselon Inc. has positioned itself as a key player in the pharmaceutical industry. This focused market positioning enhances sales opportunities by leveraging the company's strong reputation and expertise in specialized medical fields.

Vesselon Tech Stack

Vesselon uses 8 technology products and services including WordPress, MySQL, Font Awesome, and more. Explore Vesselon's tech stack below.

  • WordPress
    Content Management System
  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Webpack
    Miscellaneous
  • PHP
    Programming Languages

Vesselon's Email Address Formats

Vesselon uses at least 1 format(s):
Vesselon Email FormatsExamplePercentage
First.Last@vesselon.comJohn.Doe@vesselon.com
50%
First.Last@vesselon.comJohn.Doe@vesselon.com
50%

Frequently Asked Questions

Where is Vesselon's headquarters located?

Minus sign iconPlus sign icon
Vesselon's main headquarters is located at 101 Merritt 7 Norwalk, Connecticut 06851 US. The company has employees across 2 continents, including North AmericaEurope.

What is Vesselon's phone number?

Minus sign iconPlus sign icon
You can contact Vesselon's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Vesselon's official website and social media links?

Minus sign iconPlus sign icon
Vesselon's official website is vesselon.com and has social profiles on LinkedIn.

What is Vesselon's NAICS code?

Minus sign iconPlus sign icon
Vesselon's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Vesselon have currently?

Minus sign iconPlus sign icon
As of April 2024, Vesselon has approximately 4 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: C. L.Chief Financial Officer: N. E.President And Ceo, Co-Founder: C. L.. Explore Vesselon's employee directory with LeadIQ.

What industry does Vesselon belong to?

Minus sign iconPlus sign icon
Vesselon operates in the Pharmaceutical Manufacturing industry.

What technology does Vesselon use?

Minus sign iconPlus sign icon
Vesselon's tech stack includes WordPressMySQLFont AwesomeGoogle CloudjQueryUnderscore.jsWebpackPHP.

What is Vesselon's email format?

Minus sign iconPlus sign icon
Vesselon's email format typically follows the pattern of . Find more Vesselon email formats with LeadIQ.

How much funding has Vesselon raised to date?

Minus sign iconPlus sign icon
As of April 2024, Vesselon has raised $1M in funding. The last funding round occurred on May 29, 2015 for $1M.
Vesselon

Vesselon

Pharmaceutical ManufacturingConnecticut, United States2-10 Employees

Vesselon Inc. develops patentable drugs using an FDA-approved, biophysically activatable lipid microsphere and self-assembling liposome platform. It produces unprecedented levels of efficacy by transforming how drugs are received and acted upon by tissues and cells. The platform can extend patents and create an endless stream of proprietary drugs.

View Vesselon's digital Town Hall event at https://vesselon.com/townhall/.

Section iconCompany Overview

Headquarters
101 Merritt 7 Norwalk, Connecticut 06851 US
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $1M

    Vesselon has raised a total of $1M of funding over 2 rounds. Their latest funding round was raised on May 29, 2015 in the amount of $1M.

Section iconFunding & Financials

  • $1M

    Vesselon has raised a total of $1M of funding over 2 rounds. Their latest funding round was raised on May 29, 2015 in the amount of $1M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.